Kidswell Bio Corporation
4584.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥4,536 | ¥5,054 | ¥8,103 | ¥14,192 |
| - Cash | ¥2,995 | ¥2,231 | ¥1,067 | ¥1,161 |
| + Debt | ¥1,838 | ¥2,575 | ¥1,950 | ¥700 |
| Enterprise Value | ¥3,379 | ¥5,398 | ¥8,986 | ¥13,731 |
| Revenue | ¥5,082 | ¥2,431 | ¥2,776 | ¥1,569 |
| % Growth | 109% | -12.4% | 76.9% | – |
| Gross Profit | ¥1,639 | ¥1,039 | ¥1,526 | ¥1,019 |
| % Margin | 32.3% | 42.8% | 55% | 64.9% |
| EBITDA | ¥116 | -¥1,381 | -¥620 | -¥532 |
| % Margin | 2.3% | -56.8% | -22.3% | -33.9% |
| Net Income | -¥21 | -¥1,422 | -¥657 | -¥551 |
| % Margin | -0.4% | -58.5% | -23.7% | -35.1% |
| EPS Diluted | -0.52 | -40.23 | -20.77 | -17.86 |
| % Growth | 98.7% | -93.7% | -16.3% | – |
| Operating Cash Flow | ¥937 | -¥454 | -¥1,421 | -¥1,170 |
| Capital Expenditures | -¥6 | ¥454 | ¥1,421 | -¥0 |
| Free Cash Flow | ¥930 | -¥454 | -¥1,421 | -¥1,170 |